NDC 0003-4160 – Augtyro
Repotrectinib 160 mg/1 · Capsule · Oral
Product NDC0003-4160
Product details
- Brand name
- Augtyro
- Generic name
- repotrectinib
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA218213
- Marketed since
- November 1, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Repotrectinib 160 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0003-4160-14 | 14 CAPSULE in 1 BOTTLE (0003-4160-14) | Nov 1, 2024 |
| 0003-4160-60 | 60 CAPSULE in 1 BOTTLE (0003-4160-60) | Nov 1, 2024 |
Other Augtyro products
- 0003-4040 Repotrectinib 40 mg/1 · Capsule · E.R. Squibb & Sons, L.L.C.